Fibrinolysis: molecular mechanism and pathophysiological aspects.
D000347:Afibrinogenemia / Q000235:genetics; D001778:Blood Coagulation Disorders / Q000235:genetics; D005341:Fibrinolysin / Q000502:physiology; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000503:physiopathology; D006801:Humans; D010958:Plasminogen / Q000172:deficiency / Q000502:physiology; D010960:Plasminogen Activators / Q000172:deficiency / Q000502:physiology; D013927:Thrombosis / Q000188:drug therapy / Q000503:physiopathology; D000979:alpha-2-Antiplasmin / Q000172:deficiency / Q000502:physiology
D005343:Fibrinolytic Agents; D000979:alpha-2-Antiplasmin; D010958:Plasminogen; D010960:Plasminogen Activators; D005341:Fibrinolysin